Olon S.p.A, a world leading Active Pharmaceutical (API) contract development and manufacturing organization (CDMO) and generics supplier, announced today the acquisition of Capua BioServices S.p.A.
Paolo Tubertini, CEO of Olon, commented, "by acquiring Capua BioServices, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to be recognized as European leader in the CDMO microbial fermentation". Together, both locations can offer an impressive fermentation capacity of in total 4500 m3.
No impact on jobs is planned and Olon intends to invest in the site and pursue business development opportunities to optimize the plant's utilization and expand its customer base.
Please read the full press-release here